Special PP&P Buyer's Guide: Outsourced Compounding
June 2017 - Vol. 14 No. 6 - Page #20

Avella, a national specialty pharmacy, offers SourceB, a 503B compounding product suite that provides high-quality, safe, and effective sterile preparations designed to meet the outsourcing needs of hospitals and physician practices at a competitive price. SourceB products include sterile IV drugs, such as PCAs, epidurals, admixtures, nerve blocks, and OR syringes. In addition, many difficult-to-source products are available, including ophthalmology preparations. These therapies are produced in one of two cGMP-compliant cleanrooms, located in Texas and Arizona; together, these facilities comprise over 80,000 square feet. This operational redundancy ensures availability and on-time delivery. Rigorous potency and sterility testing for every batch is performed, along with endotoxin testing for epidural products, which exceeds USP <797> requirements. More information is available at www.avella.com/sourceb.

From Avella Specialty Pharmacy

 

To read the full article, please log in or register.

Current Issue

Our mission is to provide health system professionals with information to streamline operations and promote patient safety.

As a requester to PP&P you will receive all monthly issues, as well as our annual Resource Guide of product and service providers and all of our timely supplements on hot-button issues.

Thank you for reading PP&P, and we look forward to providing you with information to enhance the field.